CYCLOSPORIN A IMMUNOSUPPRESSION, EPSTEIN-BARR ANTIBODY, AND LYMPHOMA
Authors:
- J. NagingtonJNJ. Nagington
- J. GrayJGJ. Gray
- 1 March 1980
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 315 (8167) , 536-537
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- MALIGNANT LYMPHOMA IN CYCLOSPORIN A TREATED ALLOGRAFT RECIPIENTSThe Lancet, 1980
- Activation of Suppressor T Cells during Epstein-Barr-Virus-Induced Infectious MononucleosisNew England Journal of Medicine, 1979
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979
- Oropharyngeal Excretion of Epstein-Barr Virus by Patients with Lymphoproliferative Disorders and by Recipients of Renal HomograftsAnnals of Internal Medicine, 1978
- The use of single-radial-haemolysis for rubella antibody studiesEpidemiology and Infection, 1977
- Post-transplant malignant lymphomaThe American Journal of Medicine, 1976
- Cytomegalovirus antibody production in renal transplant patientsEpidemiology and Infection, 1971
- Immunofluorescence and Herpes-Type Virus Particles in the P3HR-1 Burkitt Lymphoma Cell LineJournal of Virology, 1967
- Immunofluorescence in Cells Derived from Burkitt's LymphomaJournal of Bacteriology, 1966